Characteristics of antibody produced during chronic treatment with LHRH

The Journal of Clinical Endocrinology and Metabolism
G M BrownA V Schally

Abstract

In a patient with hypogonadotropic hypogonadism treated with luteinizing hormone releasing hormone (LHRH), secondary failure of both subjective and hormone responses occurred at the time of appearance of binding of 125I-LHRH by the patient's serum. On electrophoresis of the patient's serum with 125I-LHRH, label was found only in the gamma globulin region. 125I-LHRH added to the patient's serum was precipitated by sheep anti-human immunoglobulin G (anti-IgG) but not by sheep anti-human immunoglobulin M (anti-IgM). Competitive displacement of 125I-LHRH by unlabeled LHRH was demonstrated while TSH releasing hormone (TRH), somatostatin and rat pituitary hormones showed no displacement when tested at concentrations 5 X 10(6) greater than that of LHRH. Studies using 14 different analogs of LHRH revealed that those with changes at the carboxy terminus showed binding similar to LHRH. It is concluded that IgG antibody to LHRH was produced in this patient by repeated administration of synthetic LHRH. It is further concluded that antibody specificity is directed toward the N terminus region.

Citations

May 6, 1982·The New England Journal of Medicine·M H MacGillivray
Sep 1, 1990·Baillière's Clinical Obstetrics and Gynaecology·Z ShohamH S Jacobs
Feb 1, 1978·Acta Physiologica Scandinavica·K Uvnäs-WallenstenR Luft
Dec 1, 1987·Journal of Endocrinological Investigation·S BenvengaJ Robbins
Oct 1, 1993·Immunology and Cell Biology·K F DowsettT E Trigg

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.